Skip to content
Home/Companies/Healthcare/Viroclinics Biosciences

Viroclinics Biosciences

Healthcare·Netherlands·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Viroclinics Biosciences?

Viroclinics Biosciences is currently owned by Summit Partners, since 2023.

Hand-verified · updated 2026-04-21

Summit Partners
Investor
Summit Partners
Fund attribution unclassified.

Key facts

HQNetherlands
SectorHealthcare

More from Summit Partners Portfolio

Other portfolio companies in the same fund.

3 Day Blinds
3 Day Blinds
Active
ConsumerUS
A+ Network
Active
TMTUS
A10 Networks
A10 Networks
Active
TMTUS
Ability Network
Active
SoftwareUS
Abode Healthcare
Active
HealthcareUS
Acacia Communications
Acacia Communications
Active
TMTUS

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
Track Viroclinics Biosciences

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Viroclinics Biosciences.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue